Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma
I. Ito, P. N. Dickson, A. M. Yousef, Z. A. Naini, M. G. White, K. G. Fleten, K. Flatmark, K. F. Fournier, N. W. Fowlkes, J. P. Shen
This study evaluates the antitumor effect of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma, showing significant tumor growth reduction.
bioRxiv · Feb 1, 2023 · PreprintCancer Biology